Cholinergic-Blocking Drugs Flashcards
Cholinergic-Blocking Drugs
also known as
Drugs that block or inhibit the actions of acetylcholine (ACh) in the parasympathetic nervous system (PSNS)
Also known as anticholinergics, parasympatholytics, and antimuscarinic drugs
Cholinergic-Blocking Drugs Mechanism of Action
Competitive antagonists
Compete with ACh for binding at muscarinic receptors in the PSNS
As a result, ACh is unable to bind to thereceptor site and cause a cholinergic effect.
When these drugs bind to receptors, they inhibit nerve transmission at these receptors.
Cholinergic-Blocking Drugs:
Two Natural Plant Alkaloids
atropine sulphate
scopolamine hydrobromide
Cholinergic-Blocking Drugs:
Three Synthetic and semisynthetic
glycopyrrolate
oxybutynin (Ditropan®)
tolterodine (Detrol®)
Drug Effects
CVS
CNS
EYE
GI
GU
GLANDULAR
RESP
Cardiovascular
-Small doses: decreased heart rate
-Large doses: increased heart rate
Central nervous system (CNS)
-Small doses: decreased muscle rigidity and tremors
-Large dose: drowsiness, disorientation, hallucinations
Eye
-Dilated pupils (mydriasis)
-Decreased accommodation caused by paralysis of ciliary muscles (cycloplegia)
Gastrointestinal (GI)
-Relaxed smooth muscle tone of GI tract
-Decreased intestinal and gastric secretions
-Decreased motility and peristalsis
Genitourinary (GU)
Relaxed detrusor muscle
Increased constriction of internal sphincter
Result: urinary retention
Glandular
Decreased sweating
Respiratory
Decreased bronchial secretions
Anticholinergic effects
dry mouth
constipation
urinary retention
confusion
Cholinergic blockers Indications: Central Nervous System
Decreasing muscle rigidity and muscle tremors
-Parkinson’s disease (becoming less trendy)
-Drug-induced extrapyramidal reactions such as those associated with antipsychotic drugs
* involuntary movements
Cholinergic blockers Indications: Cardiovascular
Affects the heart’s conduction system
-Low doses: slow the heart rate
-High doses: block inhibitory vagal effects on sinoatrial and atrioventricular node pacemaker cells
—Results in increased heart rate
Atropine
Used primarily for ________ disorders
Diagnosis of _______________
Symptomatic ________________
Severe sinus ________ with hemodynamic compromise (advanced life support)
Cardiovascular
Used primarily for cardiovascular disorders
Diagnosis of sinus node dysfunction
Symptomatic second-degree heart block
Severe sinus bradycardia with hemodynamic compromise (advanced life support)
Cholinergic blockers Indications: Respiratory
Blocking the cholinergic stimulation of the PSNS allows unopposed action of the sympathetic nervous system.
Results
-Decreased secretions from the nose, mouth, pharynx, and bronchi
-Relaxed smooth muscles in the bronchi and bronchioles
-Decreased airway resistance
-Bronchodilation
Cholinergic blockers are used to treat:
-Exercise-induced bronchospasms
-Asthma
-Chronic obstructive pulmonary disease
Cholinergic blockers Indications: GI
The PSNS controls gastric secretions and smooth muscles that produce gastric motility.
Blockade of PSNS results in:
-Decreased secretions
-Relaxation of smooth muscle
-Decreased GI motility and peristalsis
GI drugs are used to treat:
-Irritable bowel disease
-GI hypersecretory states
Cholinergic blockers Indications: Genitourinary
Reflex neurogenic bladder
Incontinence
Cholinergic blockers Contraindications
Known drug allergy
Angle-closure glaucoma
Acute asthma or other respiratory distress
Myasthenia gravis
Acute cardiovascular instability
GI or GU tract obstruction (e.g., benign prostatic hyperplasia [BPH]) or illness
Cholinergic blockers AEs
Body system/adverse effects
Cardiovascular: Increased heart rate, dysrhythmias
CNS: CNS excitation, restlessness, irritability, disorientation, hallucinations, delirium
Eye: Dilated pupils (causing blurred vision), increased intraocular pressure
GI: Decreased salivation, decreased gastric secretions, decreased motility (causing constipation)
GU: Urinary retention
Glandular: Decreased sweating
Respiratory: Decreased bronchial secretions
Toxicity and Overdose
Symptomatic and supportive therapy
Continuous electrocardiographic monitoring
Activated charcoal
Treatment of shock